Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Nien-Yi Chen"'
Autor:
Nien-Yi Chen, 陳念宜
103
Due to the popularity of the internet and the advantages that come with e-Learning, every single technologically advanced country must now include e-Learning materials for every level of schooling. Starting in 2006, all Taiwanese universitie
Due to the popularity of the internet and the advantages that come with e-Learning, every single technologically advanced country must now include e-Learning materials for every level of schooling. Starting in 2006, all Taiwanese universitie
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/99024035848041535843
Autor:
Nien-Yi Chen, 陳南亦
94
Because in real application, original ANFIS inverse learning method can not represent the inverse dynamic model of induction motor effectively. Thus in this thesis, a modified ANFIS inverse learning method is proposed. A modified training pha
Because in real application, original ANFIS inverse learning method can not represent the inverse dynamic model of induction motor effectively. Thus in this thesis, a modified ANFIS inverse learning method is proposed. A modified training pha
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/10107112581646572471
Autor:
Hsing-Mao Chu, Hui-Ming Yu, Tse Wen Chang, Chien-Jen Lin, Jiun-Bo Chen, Nien-Yi Chen, Alfur Fu-Hsin Hung, Hwan-You Chang
Publikováno v:
Molecular Immunology. 53:187-197
Surface IgD and IgM doubly positive cells comprise the major population of B cells in the human immune system. The heavy chain of membrane-bound IgD (mδ) differs from that of IgD (δ) in that mδ contains a C-terminal membrane-anchor peptide. Our gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a55b5f104e6b416af4ceea7340b6f48
https://doi.org/10.1016/j.molimm.2012.08.010
https://doi.org/10.1016/j.molimm.2012.08.010
Autor:
Pheidias C. Wu, Jiun-Bo Chen, Chien-Jen Lin, Rong Long Pan, Yu-Yu Shiung, Nien-Yi Chen, Alfur Fu-Hsin Hung, Tse Wen Chang, Chien-Sheng Lu
Publikováno v:
Molecular Immunology. 52:190-199
Type-I hypersensitivity reactions play a critical role in the pathogenesis of various allergic diseases. The successful development of the anti-IgE antibody, omalizumab, has validated IgE as an effective therapeutic target for the treatment of variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ded4c9c3be6094195195843197e880
https://doi.org/10.1016/j.molimm.2012.05.015
https://doi.org/10.1016/j.molimm.2012.05.015
Publikováno v:
Molecular Immunology. 48:1975-1982
Membrane-bound IgA (mIgA) is associated with Igα/Igβ as the B cell receptor (BCR) complex on mIgA-expressing B cells. The α chain of mIgA (mα) contains a C-terminal membrane-anchor peptide, which encompasses extracellular, transmembrane and intra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba250fb83e01693fdd51b6d672a660cd
https://doi.org/10.1016/j.molimm.2011.06.219
https://doi.org/10.1016/j.molimm.2011.06.219
Developing an antibody targeting CεmX of mIgE for the treatment of IgE-mediated diseases (HYP4P.305)
Autor:
Yueh-Hsuan Chan, Yu-Tzu Lee, Hung-Wen Chou, Pheidias Wu, Jiun-Bo Chen, Chau-Hong Li, Tien-Tien Cheng, Nien-Yi Chen, Tse-Wen Chang, Ko-Haung Lue
Publikováno v:
The Journal of Immunology. 194:123.4-123.4
CεmX (also referred to as M1’) is a discrete domain of 52 a.a. residues, located between the CH4 domain and the C-terminal membrane anchor peptide of the ε heavy chain of membrane-bound IgE (mIgE) on human B lymphocytes. Antibodies that target C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1836821c8462a70c8ced97fce7d91f8d
https://doi.org/10.4049/jimmunol.194.supp.123.4
https://doi.org/10.4049/jimmunol.194.supp.123.4
Autor:
Yueh-Hsuan Chan, Yu-Tzu Lee, Hung-Wen Chou, Pheidias C Wu, Jiun-Bo Chen, Chau-Hong Li, Tien-Tien Cheng, Nien-Yi Chen, Ko-Haung Lue, Tse-Wen Chang
Publikováno v:
The Journal of Immunology. 192:140.15-140.15
CεmX (also referred to as M1’) is a discrete domain of 52 a.a. residues, located between the CH4 domain and the C-terminal membrane anchor peptide of the ε heavy chain of membrane-bound IgE (mIgE) on human B lymphocytes. Antibodies that target C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57832f7dd971df2d748ab6ebd80ff0b5
https://doi.org/10.4049/jimmunol.192.supp.140.15
https://doi.org/10.4049/jimmunol.192.supp.140.15
Autor:
Chien-Jen Lin, Nien-Yi Nien-Yi Chen, Jiun-Bo Chen, Chien-Sheng Lu, Alfur Fu-Hsin Hung, Yu-Yu Shiung, Pheidias C. Wu, Rong-Long Pan, Tse Wen Chang
Publikováno v:
The Journal of Immunology. 188:53.7-53.7
Type-I hypersensitivity reactions play a critical role in the pathogenesis of various allergic diseases. The successful development of the anti-IgE antibody, omalizumab, has validated IgE as an effective therapeutic target for the treatment of variou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f553077d2a8f2e0c325b0c7c80cfd1e5
https://doi.org/10.4049/jimmunol.188.supp.53.7
https://doi.org/10.4049/jimmunol.188.supp.53.7
Publikováno v:
The Journal of Immunology. 186:52.19-52.19
The mIgA is associated with Igα/Igβ as the B cell receptor (BCR) complex on mIgA-expressing B cells. The α chain of mIgA (mα), comparing to the α chain of secreted IgA, contains an extra C-terminal membrane-anchor peptide, which encompasses an e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f3a89cd0c54854ef80cde04229ed0cb
https://doi.org/10.4049/jimmunol.186.supp.52.19
https://doi.org/10.4049/jimmunol.186.supp.52.19
Publikováno v:
The Journal of Immunology. 186:52.18-52.18
Membrane IgD and IgM double positive cells are the major population of B cells in the peripheral circulation. The δ chain of mIgD (mδ) differs from the δ chain of IgD in that mδ contains an extra C-terminal transmembrane-anchor peptide, of which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae3738c886282fd40c57cf9b081bae9
https://doi.org/10.4049/jimmunol.186.supp.52.18
https://doi.org/10.4049/jimmunol.186.supp.52.18